Homology Medicines

Homology Medicines, Inc. is a clinical-stage genetic medicines company working on therapies for patients suffering from rare diseases by addressing the underlying cause of the disease. 

Layoffs
Biotech

Gene therapy biotech Homology lays off 87%, seeks options

Homology Medicines has blamed the “current financing environment” for a move to lay off 87% of staff and seek a buyer for its R&D assets.
James Waldron Jul 28, 2023 8:27am
picture of a paraglider

Biogen taps new board chair—Chutes & Ladders

Mar 10, 2023 9:30am
parachute

Homology shakes up leadership—Chutes & Ladders

Sep 9, 2022 9:30am
DNA

Homology clips wings of gene therapy trial to save cash

Aug 16, 2022 7:30am
parachutes

Moderna plucks Merck marketing head for CCO job—Chutes & Ladders

Apr 29, 2022 9:00am
paper arrows upgrade upwards path

Homology gets clarity on how to resolve pheNIX gene therapy hold

Mar 24, 2022 12:27pm